>Q3: revenues up 5.9% organically - Q3 revenues came in at € 195.9m, up 10.9% (+5.9% organically.For the 9 months to 30 June 2010, operating revenue amounted to € 582.2m, up 9.1% (8.2% organic growth or 5.8% organic growth restated for the Ségur measures, booked as a reduction in personnel costs in 2023).The company is maintaining its guidance (+5% organically), in an environment it describes as “a difficult environment caused by the reform of SMR pricing”, ...
>T3 : organique à +5,9%... - Le CA T3 de LNA Santé ressort à 195,9 M€, soit +10,9% (+5,9% organique).A 9 mois, le CA Exploitation se monte à 582,2 M€, soit +9,1% (+8,2% organique ou +5,8% organique retraité des mesures Ségur, comptabilisées en réduction des charges de personnel en 2023).La société maintient sa guidance (+5% organique), dans un environnement qu’elle qualifie de « difficile, provoqué par la réforme de la tarification des SMR », avec, en effet,...
A director at LNA Sante Sa bought 3,993 shares at 23.991EUR and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
>+6.4%e forecast after +7.2% in H1 - All told, for Q3 2024 our France healthcare midcap universe should post growth with a slight decline vs H1, i.e. around +6.4%e (this figure should stand at around +5/5.5% excluding the forex effect). Such a trajectory corresponds to a slight slowdown compared to H1 (+7.2% in reported data) and remains slightly higher on an annualised basis (+5.7%e).As a reminder, over 7 years, our sector has performed well and somewhat evenly ...
We measured the impact of the contribution from Michel Barnier’s exceptional tax on 88 stocks exposed to France. Some 17 of them would experience a (negative) impact on their EPS of more than 4% on average over 2024 and 2025: LDC (-8.3%), Synergie (-8%), Eiffage (-7.9%), ADP (-7.9%), Dassault Aviation (-7%), Crit (-6.9%), Derichebourg (-6.3%), Hermès (-5.6%), Safran (-5.6%), Bouygues (-5.6%), M6 (-5.2%), Thales (-5%), TF1 (-4.9%), Nexans (-4.9%), Vinci (-4.7%), Compagnie des Alpes (...
>+6,4%e attendu après +7,2% au S1 - Dans son ensemble notre univers de Midcap Santé France devrait afficher, au T3 2024, une croissance en léger fléchissement par rapport au S1, soit environ +6,4%e (ce chiffre reviendrait à environ +5/5,5%e hors effet devises). Une telle trajectoire correspond à une légère décélération comparée au 1er semestre (+7,2% en données publiées) et reste un peu supérieure au rythme annualisé (+5,7%e).Pour rappel, sur 7 ans, notre secteur...
We measured the impact of the contribution from Michel Barnier’s exceptional tax on 88 stocks exposed to France. Some 17 of them would experience a (negative) impact on their EPS of more than 4% on average over 2024 and 2025: LDC (-8.3%), Synergie (-8%), Eiffage (-7.9%), ADP (-7.9%), Dassault Aviation (-7%), Crit (-6.9%), Derichebourg (-6.3%), Hermès (-5.6%), Safran (-5.6%), Bouygues (-5.6%), M6 (-5.2%), Thales (-5%), TF1 (-4.9%), Nexans (-4.9%), Vinci (-4.7%), Compagnie des Alpes (...
Nous avons mesuré l’impact de la contribution exceptionnelle Barnier sur 88 valeurs exposées à la France. 17 d’entre elles auraient un impact (négatif) sur leurs BPA de plus de 4% en moyenne sur 2024 et 2025 : LDC (-8,3%), Synergie (-8%), Eiffage (-7,9%) ADP (-7,9%), Dassault Aviation (-7%), Crit (-6,9%), Derichebourg (-6,3%), Hermès (-5,6%), Safran (-5,6%), Bouygues (-5,6%), M6 (-5,2%), Thalès (-5%), TF1 (-4,9%), Nexans (-4,9%), Vinci (-4,7%), Compagnie des Alpes (-4,4%), FDJ (-4%). - ...
Nous avons mesuré l’impact de la contribution exceptionnelle Barnier sur 88 valeurs exposées à la France. 17 d’entre elles auraient un impact (négatif) sur leurs BPA de plus de 4% en moyenne sur 2024 et 2025 : LDC (-8,3%), Synergie (-8%), Eiffage (-7,9%) ADP (-7,9%), Dassault Aviation (-7%), Crit (-6,9%), Derichebourg (-6,3%), Hermès (-5,6%), Safran (-5,6%), Bouygues (-5,6%), M6 (-5,2%), Thalès (-5%), TF1 (-4,9%), Nexans (-4,9%), Vinci (-4,7%), Compagnie des Alpes (-4,4%), FDJ (-4%). - ...
Tubacex is a solutions provider for the energy and mobility sectors through high value-added products (seamless stainless-steel tubes) and services. It has recently completed a successful transformation which should result in a much more stable results and cash flow profile going forward (EBITDA margin c.15% vs 10-year historical average of 9%) although 2024 will be a transition year ahead of the completion of the ADNOC contract and the closing of Mubadala’s transaction (acquisition o...
>LNA resilient on margins but also presents options for growth - Management highlighted i/ its initiatives linked to the labelling/certification of its establishments and its achievements under its Grandir Ensemble #3 plan, ii/ the attractive potential of the hospital care at home activity (several applications for territory extension, target of 35 patients/100k inhabitant compared to a national average of 27 currently), iii/ the margin structure which reveals an impr...
>LNA résiste sur ses marges mais présente aussi des options de développement - Le management a souligné i/ ses initiatives liées à la labellisation/certification de ses établissements, ou ses réalisations, au titre de son plan Grandir Ensemble #3, ii/ le potentiel attractif de l’HAD (plusieurs dossiers de demande d’extension de territoire, cible de 35 patients/100k habitant vs une moyenne nationale à 27 actuellement), iii/ la structure de marge qui fait ressortir une ...
After a challenging H1 for champagne, the industry expects volumes to stabilise in H2 ahead of a recovery in 2025. We lower our estimates for the current year for all champagne groups. In these conditions, we prefer Laurent-Perrier, the sector best-in-class which has many times proven its resilience in champagne market slumps, and upgrade our rating to Outperform vs Neutral. We downgrade Lanson-BCC to Neutral and remain at Neutral on Vranken Pommery given their more fragile profiles. - ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.